“This is about more than insulin prices; it’s about the crushing cost pressures families are facing and the very real harm that comes when corporations exploit people who have no choice but to pay,” Oregon Attorney General Dan Rayfield said.

The lawsuit alleged a years-long insulin pricing scheme that artificially inflated the price of lifesaving diabetes medications and deceived consumers about those inflated prices.

The American Hospital Association and Maine Hospital Association on Monday filed a lawsuit in U.S. District Court in Maine to stop upcoming changes to the federal 340B Drug Pricing Program.